340
Views
2
CrossRef citations to date
0
Altmetric
Original Investigation

Executive function in treatment-resistant depression before and after electroconvulsive therapy

, , , , &
Pages 624-632 | Received 17 Nov 2015, Accepted 30 Mar 2016, Published online: 12 May 2016

References

  • Addis DR, Hach S, Tippett LJ. 2016. Do strategic processes contribute to the specificity of future stimulation in depression? Br J Clin Psychol. 55:373–380.
  • Biringer E, Lundervold A, Stordal K, Mykletun A, Egeland J, Bottlender R, et al. 2005. Executive function improvement upon remission of recurrent unipolar depression. Eur Arch Psychiatry Clin Neurosci. 255:373–380.
  • Bjølseth TM, Engedal K, Benth JŠ, Dybedal GS, Gaarden TL, Tanum L. 2015. Clinical efficacy of formula-based bifrontal versus right unilateral electroconvulsive therapy (ECT) in the treatment of major depression among elderly patients: a pragmatic, randomized, assessor-blinded, controlled trial. J Affect Disord. 175:8–17.
  • Blumenfeld H, Westerveld M, Ostroff RB, Vanderhill SD, Freeman J, Necochea A. 2003. Selective frontal, parietal, and temporal networks in generalized seizures. NeuroImage. 19:1556–1566.
  • Bodnar A, Krzywotulski M, Lewandowska A, Chlopocka-Wozniak M, Bartkowska-Sniatkowska A, Michalak M, et al. 2015. Electroconvulsive therapy and cognitive functions in treatment-resistant depression. World J Biol Psychiatry. 20:1–6.
  • Chan RC, Shum D, Toulopoulou T, Chen EY. 2008. Assessment of executive functions: review of instruments and identification of critical issues. Arch Clin Neuropsychol. 23:201–216.
  • Divac N, Jasovic M, Djukic L, Vujnovic M, Babic D, Bajcetic M, et al. 2004. Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia. Pharmacoepidemiol Drug Saf. 13:315–322.
  • Dunne RA, McLoughlin DM. 2012. Systematic review and meta-analysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression. World J Biol Psychiatry. 13:248–258.
  • Egerházi A, Balla P, Ritzl A, Varga Z, Frecska E, Berecz R. 2013. Automated Neuropsychological Test Battery in depression - preliminary data. Neuropsychopharmacol Hung. 15:5–11.
  • Eschweiler GW, Vonthein R, Bode R, Huell M, Conca A, Peters O, et al. 2007. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression. J Affect Disord. 101:149–157.
  • Falconer DW, Cleland J, Fielding S, Reid IC. 2010. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory. Psychol Med. 40:1017–1025.
  • Feldmann D, Schuepbach D, von Rickenbach B, Theodoridou A, Hell D. 2006. Association between two distinct executive tasks in schizophrenia: a functional transcranial Doppler sonography study. BMC Psychiatry. 6:25.
  • Fernie G, Bennett DM, Currie J, Perrin JS, Reid IC. 2014. Detecting objective and subjective cognitive effects of electroconvulsive therapy: intensity, duration and test utility in a large clinical sample. Psychological Medicine. 44:2985–2994.
  • Friedman NP, Miyake A, Corley RP, Young SE, DeFries JC, Hewitt JK. 2006. Not all executive functions are related to intelligence. Psychological Science 17:172–179.
  • Getz GE, Edner BJ, Nickell PV. 2014. The effect of electroconvulsive therapy on executive functioning in a treatment-resistant man with depression: a case report. J Ect. 30:e11–e12.
  • Grant MM, Thase ME, Sweeney JA. 2001. Cognitive disturbance in outpatient depressed younger adults: evidence of modest impairment. Biol Psychiatry. 50:35–43.
  • Gupta M, Holshausen K, Best MW, Jokic R, Milev R, Bernard T, et al. 2013. Relationships among neurocognition, symptoms, and functioning in treatment-resistant depression. Arch Clin Neuropsychol. 28:272–281.
  • Guy W. 1976. ECDEU assessment manual for psycopharmacology. Rockville (MD): US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug abuse, and Mental Health Administration.
  • Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatr. 23:56–62.
  • Jovanovic V, Gavrilov-Jerkovic V, Zuljevic D, Brdaric D. 2014. Psychometric evaluation of the depression anxiety stress scales-21 (DASS-21) in a Serbian student sample. Psihologija. 47:93–112.
  • Kalogerakou S, Oulis P, Anyfandi E, Konstantakopoulos G, Papakosta VM, Kontis D, et al. 2015. Episodic visual learning/memory and attentional flexibility in patients with major depressive disorder after clinically effective electroconvulsive therapy. J Ect. 31:246–252.
  • Leiknes KA, von Schweder LJ, Høie B. 2012. Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav. 2:283–344.
  • Lovibond SH, Lovibond PF. 1995. Manual for the depression anxiety stress scales. Sydney: Psychology Foundation of Australia.
  • Maric NP, Stojanovic Z, Andric S, Soldatovic I, Dolic M, Spiric Z. 2016. The acute and medium-term effects of treatment with electroconvulsive therapy on memory in patients with major depressive disorder. Psychol Med. 46:797–806.
  • McClintock SM, Husain MM, Greer TL, Cullum CM. 2010. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology. 24:9–34.
  • Moreines JL, McClintock SM, Holtzheimer PE. 2011. Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimul. 4:17–27.
  • Moreines JL, McClintock SM, Kelley ME, Holtzheimer PE, Mayberg HS. 2014. Neuropsychological function before and after subcallosal cingulate deep brain stimulation in patients with treatment-resistant depression. Depress Anxiety. 31:690–698.
  • Naismith SL, Hickie IB, Turner K, Little CL, Winter V, Ward PB, et al. 2003. Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. J Clin Exp Neuropsychol. 25:866–877.
  • Northdurfter C, Eser D, Schule C, Zwanzger P, Marcuse A, Noack I, et al. 2006. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 7:162–170.
  • Ozonoff S, Cook I, Coon H, Dawson G, Joseph RM, Klin A, et al. 2004. Performance on cambridge neuropsychological test automated battery subtests sensitive to frontal lobe function in people with autistic disorder: Evidence from the Collaborative Programs of Excellence in Autism Network. J Autism Dev Disord. 34:139–150.
  • Pangman VC, Sloan J, Guse L. 2000. An examination of psychometric properties of the mini-mental state examination and the standardized mini-mental state examination: implications for clinical practice. Appl Nurs Res. 13:209–213.
  • Perrin JS, Merz S, Bennett DM, Currie J, Douglas J, Steele DJ, et al. 2012. Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder. Proc Natl Acad Sci USA. 109:5464–5468.
  • Petrides G, Fink M. 1996. The “half-age” stimulation strategy for ECT dosing. Convuls Ther. 12:138–146.
  • Ranjkesh F, Barekatain M, Akuchakian S. 2005. Bifrontal versus right unilateral and bitemporal electroconvulsive therapy in major depressive disorder. J Ect. 21:207–210.
  • Semkovska M, McLoughlin DM. 2010. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 68:568–577.
  • Siddiqui SV, Chatterjee U, Kumar D, Siddiqui A, Goyal N. 2008. Neuropsychology of prefrontal cortex. Indian J Psychiatry. 50:202–208.
  • Snyder HR. 2013. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull. 139:81–132.
  • Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O, et al. 1999. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol. 9:83–91.
  • Spiric Z, Stojanovic Z, Samardzic R, Milovanovic S, Gazdag G, Maric NP. 2014. Electroconvulsive therapy practice in Serbia today. Psychiatria Danubina. 26:66–69.
  • Thirthalli J, Rakesh G, Gangadhar BN. 2010. Antiepileptic drugs-ECT combination: Need for systematic studies. World J Biol Psychiatry. 11:919–920.
  • Trevino K, McClintock SM, McDonald Fischer N, Vora A, Husain MM. 2014. Defining treatment-resistant depression: a comprehensive review of the literature. Ann Clin Psychiatry. 26:222–232.
  • Tsaltas E, Kalogerakou S, Papakosta VM, Kontis D, Theochari E, Koutroumpi M. 2011. Contrasting patterns of deficits in visuospatial memory and executive function in patients with major depression with and without ECT referral. Psychol Med. 41:983–995.
  • Warnell RL, Swartz CM, Thomson A. 2011. Clinically insubstantial cognitive side effects of bitemporal electroconvulsive therapy at 0.5 msec pulse width. Ann Clin Psychiatry. 23:257–262.
  • Wechsler D. 1981. Manual for the Wechsler Adult Intelligence Scale – Revised (WAIS-R). San Antonio (TX): Psychological Corporation.
  • Welsh MC, Pennington BF. 1988. Assessing frontal lobe functioning in children: Views from developmental psychology. Dev Neuropsychol. 4:199–230.
  • Zelazo PD, Carter A, Reznick JS, Frye D. 1997. Early development of executive function: A problem-solving framework. Rev Gen Psychol 1:198–226.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.